These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 20434022)
1. Comparative effectiveness reviews and the impact of funding bias. Gartlehner G; Fleg A J Clin Epidemiol; 2010 Jun; 63(6):589-90. PubMed ID: 20434022 [No Abstract] [Full Text] [Related]
2. Industry sponsorship in research and publishing: who is really to blame for perceived bias? Amsden GW Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974 [No Abstract] [Full Text] [Related]
3. Pharmaceutical company-sponsored drug trials: what are we to believe? Shekelle P J Clin Epidemiol; 2010 Feb; 63(2):126-7. PubMed ID: 19836207 [No Abstract] [Full Text] [Related]
4. Addressing conflict in strategic literature reviews: disclosure is not enough. Michaels D J Epidemiol Community Health; 2009 Aug; 63(8):599-600. PubMed ID: 19596838 [No Abstract] [Full Text] [Related]
6. Reporting bias in industry-supported medication trials presented at the American Psychiatric Association meeting. Sen S; Prabhu M J Clin Psychopharmacol; 2012 Jun; 32(3):435. PubMed ID: 22561482 [No Abstract] [Full Text] [Related]
7. [The effectiveness of antidepressants is in doubt]. Kiefer B Rev Med Suisse; 2008 Apr; 4(154):1072. PubMed ID: 18557541 [No Abstract] [Full Text] [Related]
8. Double blind random bluff. Moncrieff J; Double D Ment Health Today; 2003 Nov; ():24-6. PubMed ID: 14689600 [No Abstract] [Full Text] [Related]
9. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry. Dorfman HL; Reig LP Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876 [No Abstract] [Full Text] [Related]
11. Industry sponsorship and authorship of clinical trials over 20 years. Buchkowsky SS; Jewesson PJ Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982 [TBL] [Abstract][Full Text] [Related]
12. Selective publication of antidepressant trials. Ninan PT; Poole RM; Stiles GL N Engl J Med; 2008 May; 358(20):2181; author reply 2181-2. PubMed ID: 18494076 [No Abstract] [Full Text] [Related]
13. [Financial interests characterize published reports on coxiber. Whom can we rely on?]. Håkansson J Lakartidningen; 2002 Oct; 99(40):3930-1. PubMed ID: 12422746 [No Abstract] [Full Text] [Related]
14. Do financial factors such as author page charges and industry funding impact on the nature of published research in infectious diseases? Liyanage SS; Raina Macintyre C Health Info Libr J; 2006 Sep; 23(3):214-22. PubMed ID: 16911128 [TBL] [Abstract][Full Text] [Related]
15. Comparison of schizophrenia drugs often favors firm funding study. Vendantam S Washington Post; 2006 Apr; ():A1, A6. PubMed ID: 16856276 [No Abstract] [Full Text] [Related]
16. Industry sponsored bias in cost effectiveness analyses. John-Baptiste A; Bell C BMJ; 2010 Oct; 341():c5350. PubMed ID: 20943724 [No Abstract] [Full Text] [Related]
18. [Industry-promoted research and the significance principle]. Klin Monbl Augenheilkd; 2001 May; 218(5):A90-1. PubMed ID: 11417352 [No Abstract] [Full Text] [Related]
19. Evaluating solutions to sponsorship bias. Doucet M; Sismondo S J Med Ethics; 2008 Aug; 34(8):627-30. PubMed ID: 18667655 [TBL] [Abstract][Full Text] [Related]
20. [Selective publication of research into antidepressants: consequences for the practice guideline 'depression']. Doornbos B; de Jonge P; Bockting CL Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1406-8. PubMed ID: 18624001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]